[Repetitive acute pancreatitis in a late-diagnosed cystic fibrosis: prevention of relapses by octreotide in the long term].
We report on the case of a 35 year-old woman who was initially admitted for acute pancreatitis in october 1995. The patient was suffering from asthma (since childhood) and diffuse abdominal pain (since adolescence). The diagnosis of cystic fibrosis was made fortuitously during a sterility evaluation. After extensive etiological screening the acute pancreatitis was considered to be a manifestation of the cystic fibrosis. Despite therapy with pancreatic enzymes, the patient continued to suffer from chronic abdominal pain. High intake of analgesics was required. Until December 1995, the patient was repeatedly admitted for episodes of acute pancreatitis. In January 1996, we initiated a preventive treatment with subcutaneous octreotide between 100 and 200 microgram, three time a day. Thereafter, there were fewer episodes of pancreatitis and the consumption of analgesics decreased. Side effects of octreotide were intermittent diarrhea and development of cholelithiasis that was complicated by biliary migration in November 1998. In June 1999, the prolonged-release form of the molecule was given without modification of the efficacy.
Weber
A
A
Service de Gastroentérologie, Hôpital J.Minjoz, Cedex, France. audrey.weber@wanadoo.fr
Queneau
P E
PE
Polio
J C
JC
Koch
S
S
Fellmann
F
F
Sauve
G
G
Carayon
P
P
D000208:Acute Disease; D000328:Adult; D003550:Cystic Fibrosis / Q000150:complications* / Q000175:diagnosis*; D005260:Female; D005765:Gastrointestinal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D015282:Octreotide / Q000009:adverse effects / Q000627:therapeutic use*; D010195:Pancreatitis / Q000209:etiology* / Q000517:prevention & control*; D012008:Recurrence
D005765:Gastrointestinal Agents; D015282:Octreotide
Poussées à répétition de pancréatite aiguë dans une mucoviscidose à révélation tardive: prévention par octréotide au long cours.